128 related articles for article (PubMed ID: 1719559)
1. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.
Schneider DJ; Sobel BE
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9959-63. PubMed ID: 1719559
[TBL] [Abstract][Full Text] [Related]
2. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells.
Schneider DJ; Nordt TK; Sobel BE
Diabetes; 1992 Jul; 41(7):890-5. PubMed ID: 1612205
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells.
Reilly CF; McFall RC
J Biol Chem; 1991 May; 266(15):9419-27. PubMed ID: 2033043
[TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.
Fattal PG; Schneider DJ; Sobel BE; Billadello JJ
J Biol Chem; 1992 Jun; 267(18):12412-5. PubMed ID: 1618746
[TBL] [Abstract][Full Text] [Related]
5. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
[TBL] [Abstract][Full Text] [Related]
6. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
7. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
Lalou C; Silve C; Rosato R; Segovia B; Binoux M
Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells.
Dimova EY; Möller U; Herzig S; Fink T; Zachar V; Ebbesen P; Kietzmann T
Thromb Haemost; 2005 Jun; 93(6):1176-84. PubMed ID: 15968405
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes.
Kooistra T; Bosma PJ; Töns HA; van den Berg AP; Meyer P; Princen HM
Thromb Haemost; 1989 Sep; 62(2):723-8. PubMed ID: 2683191
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.
Nordt TK; Schneider DJ; Sobel BE
Circulation; 1994 Jan; 89(1):321-30. PubMed ID: 8281664
[TBL] [Abstract][Full Text] [Related]
11. Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids.
Schneider DJ; Sobel BE
Coron Artery Dis; 1996 Nov; 7(11):813-7. PubMed ID: 8993938
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications.
Miyagawa R; Asakura T; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2010 May; 21(3):144-50. PubMed ID: 20299979
[TBL] [Abstract][Full Text] [Related]
13. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
Bale LK; Conover CA
Endocrinology; 1992 Aug; 131(2):608-14. PubMed ID: 1379162
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated expression of plasminogen activator inhibitor-1 in Hep G2 cells: interrelationship between insulin and insulin-like growth factor 1.
Anfosso F; Alessi MC; Nalbone G; Chomiki N; Henry M; Juhan-Vague I
Thromb Haemost; 1995 Feb; 73(2):268-74. PubMed ID: 7792742
[TBL] [Abstract][Full Text] [Related]
15. Synergistic induction of plasminogen activator inhibitor type-1 in HEP G2 cells by thrombin and transforming growth factor-beta.
Hopkins WE; Fujii S; Sobel BE
Blood; 1992 Jan; 79(1):75-81. PubMed ID: 1309426
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1990 Jan; 4(1):171-8. PubMed ID: 2157975
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
[TBL] [Abstract][Full Text] [Related]
18. Mediators of induction of augmented expression of plasminogen activator inhibitor type-1 in Hep G2 cells by platelets.
Hopkins WE; Westerhausen DR; Fujii S; Billadello JJ; Sobel BE
Thromb Haemost; 1991 Aug; 66(2):239-45. PubMed ID: 1663280
[TBL] [Abstract][Full Text] [Related]
19. The effects of insulin-like growth factor-1 on plasminogen activator inhibitor-1 synthesis and secretion: results from in vitro and in vivo studies.
Padayatty SJ; Orme S; Zenobi PD; Stickland MH; Belchetz PE; Grant PJ
Thromb Haemost; 1993 Dec; 70(6):1009-13. PubMed ID: 8165592
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
